The first stop for professional medicines advice

Medicines planning

60 results

RelevanceNewest firstOldest firstTitle
Applied filters

Preparing to use natalizumab biosimilar

6 February 2024

Legal mechanisms and contrast agents

15 July 2024

Implementing ustekinumab biosimilar

4 September 2024

Including medicines with Risk Minimisation Measures (RMM) in PGDs

16 March 2021This article reflects MHRA guidance on the use of PGDs for medications which have risk minimisation measures (RMM).

Biosimilars

Regularly updated biosimilars material, in addition to our annual outputs. Includes specific information on ranibizumab for ocular use.

Using medicines at more than one location under a single PGD

16 November 2021A single PGD can be used to supply or administer medicines in more than one location. PGDs do not need to relate to specific premises.

New Product Evaluations

11 October 2021A list of new product evaluations that are freely available to NHS staff via the internet

Using our annual medicines planning content: Prescribing Outlook

31 October 2023Users should be aware of the constraints and assumptions in creating our annual Prescribing Outlook publications, as well as their responsibilities for use.

Annual medicines planning

Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.

Preparing to use tocilizumab biosimilar

5 March 2024